Literature DB >> 4219909

Diffuse normolipaemic plane xanthomatosis. An abnormal complement component profile.

R E Jordon, F C McDuffie, R A Good, N K Day.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4219909      PMCID: PMC1537989     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  23 in total

1.  Diffuse normolipemic plane xanthoma. Generalized xanthelasma.

Authors:  J ALTMAN; R K WINKELMANN
Journal:  Arch Dermatol       Date:  1962-05

2.  The complement system in bullous pemphigoid. I. Complement and component levels in sera and blister fluids.

Authors:  R E Jordon; N K Day; W M Sams; R A Good
Journal:  J Clin Invest       Date:  1973-05       Impact factor: 14.808

3.  Immune hemolysis: a simplified method for the preparation of EAC'4 with guinea pig or with human complement.

Authors:  T Borsos; H J Rapp
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

4.  [Myeloma, hyperlipemia and xanthomatosis].

Authors:  J L Beaumont; B Jacotot; V Beaumont; J Warnet; C Vilain
Journal:  Nouv Rev Fr Hematol       Date:  1965 May-Jun

5.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

6.  Generalized plane xanthoma and systemic disease.

Authors:  P J Lynch; R K Winkelmann
Journal:  Arch Dermatol       Date:  1966-06

7.  Methods for the separation, purification and measurement of nine components of hemolytic complement in guinea-pig serum.

Authors:  R A Nelson; J Jensen; I Gigli; N Tamura
Journal:  Immunochemistry       Date:  1966-03

8.  IMMUNOLOGICAL STUDIES OF THE 11S PROTEIN COMPONENT OF THE HUMAN COMPLEMENT SYSTEM.

Authors:  J H MORSE; C L CHRISTIAN
Journal:  J Exp Med       Date:  1964-02-01       Impact factor: 14.307

9.  ISOLATION OF BETA IF-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENT.

Authors:  U R NILSSON; H J MUELLER-EBERHARD
Journal:  J Exp Med       Date:  1965-08-01       Impact factor: 14.307

10.  ISOLATION AND DESCRIPTION OF THE FOURTH COMPONENT OF HUMAN COMPLEMENT.

Authors:  H J MUELLER-EBERHARD; C E BIRO
Journal:  J Exp Med       Date:  1963-09-01       Impact factor: 14.307

View more
  5 in total

1.  Acquired c1-inhibitor deficiencies in lymphoproliferative diseases with serum immunoglobulin abnormalities. A study of three cases.

Authors:  G Hauptmann; J M Lang; M L North; F Oberling; G Mayer; P Lachmann
Journal:  Blut       Date:  1976-03

2.  Classical pathway complement activation in association with paraproteinaemia.

Authors:  P F Naish; C Collins; J Barratt
Journal:  Immunology       Date:  1977-10       Impact factor: 7.397

3.  Fast liver catabolism of C1q in patients with paraproteinaemia and depletion of the classical pathway of complement.

Authors:  J A Schifferli; M Pascual; G Steiger; M Schapira; J E Ryser; J Estreicher; A Dash
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy.

Authors:  G Hauptmann; F Petitjean; J M Lang; F Oberling
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

Review 5.  Diffuse normolipemic plane xanthoma associated with monoclonal gammopathy.

Authors:  Yoon K Cohen; David J Elpern
Journal:  Dermatol Pract Concept       Date:  2015-10-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.